Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells
Open Access
- 26 May 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 110 (6), 921-927
- https://doi.org/10.1002/ijc.20216
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Common Human UGT1A Polymorphisms and the Altered Metabolism of Irinotecan Active Metabolite 7-Ethyl-10-hydroxycamptothecin (SN-38)Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2002
- O6‐Methylguanine‐DNA Methyltransferase (MGMT) as a Determinant of Resistance to Camptothecin DerivativesJapanese Journal of Cancer Research, 2002
- An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cellsCancer Letters, 1999
- Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein.Cancer Chemotherapy and Pharmacology, 1998
- The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitroJapanese Journal of Cancer Research, 1997
- The Current Status of Camptothecin Analogues as Antitumor AgentsJNCI Journal of the National Cancer Institute, 1993
- Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives: Carbamate-Linked, Water-Soluble Derivatives of 7-Ethyl-10-hydroxycamptothecin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in XenograftsScience, 1989
- Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.Proceedings of the National Academy of Sciences, 1987
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966